One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus.

Abstract:

:Retrovirus-mediated gene transfer into long-lived human pluripotent hematopoietic stem cells (HSCs) is a widely sought but elusive goal. A major problem is the quiescent nature of most HSCs, with the perceived requirement for ex vivo prestimulation in cytokines to induce stem cell cycling and allow stable gene integration. However, ex vivo culture may impair stem cell function, and could explain the disappointing clinical results in many current gene transfer trials. To address this possibility, we examined the ex vivo survival of nonobese diabetic/severe combined immune-deficient (NOD/SCID) repopulating cells (SRCs) over 3 days. After 1 day of culture, the SRC number and proliferation declined twofold, and was further reduced by day 3; self-renewal was only detectable in noncultured cells. To determine if the period of ex vivo culture could be shortened, we used a vesicular stomatitis virus G protein (VSV-G) pseudotyped retrovirus vector that was concentrated to high titer. The results showed that gene transfer rates were similar without or with 48 hours prestimulation. Thus, the use of high-titer VSV-G pseudotyped retrovirus may minimize the loss of HSCs during culture, because efficient gene transfer can be obtained without the need for extended ex vivo culture.

journal_name

Blood

journal_title

Blood

authors

Rebel VI,Tanaka M,Lee JS,Hartnett S,Pulsipher M,Nathan DG,Mulligan RC,Sieff CA

subject

Has Abstract

pub_date

1999-04-01 00:00:00

pages

2217-24

issue

7

eissn

0006-4971

issn

1528-0020

journal_volume

93

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Approach to the treatment of multiple myeloma: a clash of philosophies.

    abstract::In this Perspective, we summarize some of the most contentious issues surrounding diagnosis and treatment of myeloma. We outline how a fundamental clash of philosophies, cure versus control, may be at the heart of many of the controversies. From the very definition of the disease to risk stratification to the validity...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-297853

    authors: Rajkumar SV,Gahrton G,Bergsagel PL

    更新日期:2011-09-22 00:00:00

  • Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone.

    abstract::Relapse following remission induction chemotherapy remains a barrier to survival in approximately 20% of children suffering from acute lymphoblastic leukemia (ALL). To investigate the mechanism of relapse, 27 matched diagnosis and relapse ALL samples were analyzed for clonal populations using polymerase chain reaction...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-01-067785

    authors: Choi S,Henderson MJ,Kwan E,Beesley AH,Sutton R,Bahar AY,Giles J,Venn NC,Pozza LD,Baker DL,Marshall GM,Kees UR,Haber M,Norris MD

    更新日期:2007-07-15 00:00:00

  • Identification and characterization of osteoclast progenitors by clonal analysis of hematopoietic cells.

    abstract::We have identified a distinct population of colony-forming cells that give rise to mononuclear cells expressing an enzyme marker and other features of the osteoclast in bone marrow cultures stimulated by conditioned medium of a murine tumor cell line. These colony-forming cells were defined as osteoclast colony-formin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lee MY,Lottsfeldt JL,Fevold KL

    更新日期:1992-10-01 00:00:00

  • Farnesyltransferase inhibitor R115777 in myelodysplastic syndrome: clinical and biologic activities in the phase 1 setting.

    abstract::R115777 is a potent farnesyltransferase (FTase) inhibitor with substantial antitumor activity in preclinical models. We conducted a phase 1 study (3 + 3 design) of R115777 in patients with myelodysplastic syndrome (MDS). R115777 was administered twice daily (3-weeks-on/1-week-off schedule for 8 weeks) (starting dosage...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2002-11-3359

    authors: Kurzrock R,Kantarjian HM,Cortes JE,Singhania N,Thomas DA,Wilson EF,Wright JJ,Freireich EJ,Talpaz M,Sebti SM

    更新日期:2003-12-15 00:00:00

  • Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis.

    abstract::Prolylcarboxypeptidase (PRCP) activates prekallikrein to plasma kallikrein, leading to bradykinin liberation, and degrades angiotensin II. We now identify PRCP as a regulator of blood vessel homeostasis. β-Galactosidase staining in PRCP(gt/gt) mice reveals expression in kidney and vasculature. Invasive telemetric moni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-318527

    authors: Adams GN,LaRusch GA,Stavrou E,Zhou Y,Nieman MT,Jacobs GH,Cui Y,Lu Y,Jain MK,Mahdi F,Shariat-Madar Z,Okada Y,D'Alecy LG,Schmaier AH

    更新日期:2011-04-07 00:00:00

  • FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma.

    abstract::Women treated at young ages with supradiaphragmatic radiotherapy for Hodgkin lymphoma (HL) have a highly increased risk of breast cancer. For personalized advice and follow-up regimens for patients, information is needed on how the radiotherapy-related risk is affected by other breast cancer risk factors. Genome-wide ...

    journal_title:Blood

    pub_type: 杂志文章,meta分析

    doi:10.1182/blood-2011-10-383380

    authors: Ma YP,van Leeuwen FE,Cooke R,Broeks A,Enciso-Mora V,Olver B,Lloyd A,Broderick P,Russell NS,Janus C,Ashworth A,Houlston RS,Swerdlow AJ

    更新日期:2012-01-26 00:00:00

  • RUNX1 and NF-E2 upregulation is not specific for MPNs, but is seen in polycythemic disorders with augmented HIF signaling.

    abstract::Overexpression of transcription factors runt-related transcription factor 1 (RUNX1) and nuclear factor, erythroid-derived 2 (NF-E2) was reported in granulocytes of patients with polycythemia vera and other myeloproliferative neoplasms (MPNs). Further, a transgenic mouse overexpressing the NF-E2 transgene was reported ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-534222

    authors: Kapralova K,Lanikova L,Lorenzo F,Song J,Horvathova M,Divoky V,Prchal JT

    更新日期:2014-01-16 00:00:00

  • A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells.

    abstract::Various virus infections cause dysfunctional hemostasis and in some instances lead to the development of viral hemorrhagic fever syndrome. How do diverse viruses induce the expression of tissue factor on vascular cells? We hypothesize that a direct stimulation of pattern recognition receptors (PRR) by viral nucleic ac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-02-137901

    authors: Shibamiya A,Hersemeyer K,Schmidt Wöll T,Sedding D,Daniel JM,Bauer S,Koyama T,Preissner KT,Kanse SM

    更新日期:2009-01-15 00:00:00

  • T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells.

    abstract::In diffuse large B-cell lymphoma (DLBCL), the number of circulating monocytes and neutrophils represents an independent prognostic factor. These cell subsets include monocytic and granulocytic myeloid-derived suppressor cells (M- and G-MDSCs) defined by their ability to suppress T-cell responses. MDSCs are a heterogen...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2015-08-662783

    authors: Azzaoui I,Uhel F,Rossille D,Pangault C,Dulong J,Le Priol J,Lamy T,Houot R,Le Gouill S,Cartron G,Godmer P,Bouabdallah K,Milpied N,Damaj G,Tarte K,Fest T,Roussel M

    更新日期:2016-08-25 00:00:00

  • Manipulating leukocyte interactions in vivo through optogenetic chemokine release.

    abstract::Light-mediated release of signaling ligands, such as chemoattractants, growth factors, and cytokines is an attractive strategy for investigation and therapeutic targeting of leukocyte communication and immune responses. We introduce a versatile optogenetic method to control ligand secretion, combining UV-conditioned e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-11-684852

    authors: Sarris M,Olekhnovitch R,Bousso P

    更新日期:2016-06-09 00:00:00

  • Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.

    abstract::Vaccination of patients with cancer using dendritic cells (DCs) was shown to be effective for B-cell lymphoma and malignant melanoma. Here we provide evidence that patients with advanced breast and ovarian cancer can be efficiently vaccinated with autologous DCs pulsed with HER-2/neu- or MUC1-derived peptides. Ten pat...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Brossart P,Wirths S,Stuhler G,Reichardt VL,Kanz L,Brugger W

    更新日期:2000-11-01 00:00:00

  • ADAMTS13 turns 3.

    abstract::It has now been 3 years since the von Willebrand factor (VWF)-cleaving protease implicated in thrombocytopenic purpura (TTP) pathogenesis was identified as ADAMTS13 (a disintegrin-like and metalloprotease with thrombospondin type 1 motif 13). More than 50 ADAMTS13 mutations resulting in familial TTP have been reported...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2004-10-4097

    authors: Levy GG,Motto DG,Ginsburg D

    更新日期:2005-07-01 00:00:00

  • A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.

    abstract::This article reports a Glanzmann thrombasthenia (GT) patient, N.M., with a point mutation in the third cysteine-rich repeat of beta3-integrin or platelet glycoprotein (GP) IIIa, leading to the expression of a constitutively activated fibrinogen receptor. The diagnosis of GT was based on a severely reduced platelet-agg...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.8.2432

    authors: Ruiz C,Liu CY,Sun QH,Sigaud-Fiks M,Fressinaud E,Muller JY,Nurden P,Nurden AT,Newman PJ,Valentin N

    更新日期:2001-10-15 00:00:00

  • Growth characteristics of circulating hematopoietic progenitor cells from patients with essential thrombocythemia.

    abstract::Peripheral blood mononuclear cells from five patients with essential thrombocythemia (ET) were cultured in vitro to evaluate restricted megakaryocytic (CFU-Meg), myeloid (CFU-GM), and erythroid (BFU-E) progenitor cell development. Varying concentrations of aplastic canine serum served as the source of megakaryocyte co...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mazur EM,Cohen JL,Bogart L

    更新日期:1988-06-01 00:00:00

  • How I treat acute myeloid leukemia in the era of new drugs.

    abstract::The acute myeloid leukemia (AML) treatment landscape has changed substantially since 2017. New targeted drugs have emerged, including venetoclax to target B-cell lymphoma 2, midostaurin and gilteritinib to target FLT3, and ivosidenib and enasidenib to target mutant isocitrate dehydrogenase 1 and 2, respectively. Other...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001239

    authors: DiNardo CD,Wei AH

    更新日期:2020-01-09 00:00:00

  • Bcl-x(L) prevents apoptosis of late-stage erythroblasts but does not mediate the antiapoptotic effect of erythropoietin.

    abstract::The long form of B-cell lymphoma-x (Bcl-x(L)), an outer mitochondrial membrane protein, has been proposed to mediate the antiapoptotic action of erythropoietin on erythroid progenitor cells and to be necessary for heme synthesis in erythroblasts. Mice with conditional knockout of Bcl-x(L) (conditional bcl-x(-/-) mice)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-11-4344

    authors: Rhodes MM,Kopsombut P,Bondurant MC,Price JO,Koury MJ

    更新日期:2005-09-01 00:00:00

  • Functional alteration of red blood cells by a megadalton protein of Plasmodium falciparum.

    abstract::Proteins exported from Plasmodium falciparum parasites into red blood cells (RBCs) interact with the membrane skeleton and contribute to the pathogenesis of malaria. Specifically, exported proteins increase RBC membrane rigidity, decrease deformability, and increase adhesiveness, culminating in intravascular sequestra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-157735

    authors: Glenister FK,Fernandez KM,Kats LM,Hanssen E,Mohandas N,Coppel RL,Cooke BM

    更新日期:2009-01-22 00:00:00

  • Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1.

    abstract::We analyzed the expression of myelomonocytic-associated antigens on lymphocytes from B cell chronic lymphocytic leukemia (B-CLL) patients. Blood mononuclear cells were depleted of monocytes by one-step Percoll density gradient centrifugation and tested for antigen expression by fluorescent microscopy and flow cytometr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morabito F,Prasthofer EF,Dunlap NE,Grossi CE,Tilden AB

    更新日期:1987-12-01 00:00:00

  • Hematopoietic bone marrow recovery after radiation therapy: MRI evaluation.

    abstract::Magnetic resonance imaging (MRI) is able to detect the increase of adipocytes in the hematopoietic bone marrow that occurs as a consequence of radiotherapy and is indicative of the loss of myeloid tissue. By monitoring this process, it is also possible to determine the recovery of the bone marrow. The amount of viable...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Casamassima F,Ruggiero C,Caramella D,Tinacci E,Villari N,Ruggiero M

    更新日期:1989-05-01 00:00:00

  • Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

    abstract::Sickle cell disease is a common hemolytic disorder with a broad range of complications, including vaso-occlusive episodes, acute chest syndrome (ACS), pain, and stroke. Heme oxygenase-1 (gene HMOX1; protein HO-1) is the inducible, rate-limiting enzyme in the catabolism of heme and might attenuate the severity of outco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-361642

    authors: Bean CJ,Boulet SL,Ellingsen D,Pyle ME,Barron-Casella EA,Casella JF,Payne AB,Driggers J,Trau HA,Yang G,Jones K,Ofori-Acquah SF,Hooper WC,DeBaun MR

    更新日期:2012-11-01 00:00:00

  • Red cell rheology in stomatocyte-echinocyte transformation: roles of cell geometry and cell shape.

    abstract::The influence of the shape of the red blood cell during stomatocyte-echinocyte transformation on its deformability was studied by microsieving through pores with diameters of 2.6, 4.5, and 6.9 micron. A stomatocytic transformation was produced by chlorpromazine (0.02, 0.1, and 0.5 mmol/L) and an echinocytic transforma...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reinhart WH,Chien S

    更新日期:1986-04-01 00:00:00

  • Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrow-hematopoietic progenitor cells expressing SDF-1-intrakine.

    abstract::Both SDF-1 and CXCR4 disruption are lethal to mice at the embryonic stage and cause abnormalities in B lymphopoiesis, myelopoiesis, cardiogenesis, vasculogenesis, and cerebellar development. To investigate the role of SDF-1 and CXCR4 in hematopoiesis during the adult stage, mice reconstituted with bone marrow-derived ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Onai N,Zhang Yy,Yoneyama H,Kitamura T,Ishikawa S,Matsushima K

    更新日期:2000-09-15 00:00:00

  • Half-lives of beta and gamma globin messenger RNAs and of protein synthetic capacity in cultured human reticulocytes.

    abstract::The turnover rates of beta and gamma globin messenger RNAs and of beta and gamma globin protein synthesis in human reticulocytes have been measured. Our goal was to determine whether beta globin mRNA is significantly more stable than gamma globin mRNA during the final stages of erythroid cell maturation. Such a result...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ross J,Sullivan TD

    更新日期:1985-11-01 00:00:00

  • Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation.

    abstract::Activated protein C is a potent anticoagulant and profibrinolytic enzyme that can be derived from the vitamin-K-dependent serine protease zymogen, protein C, by the action of thrombin. Protein C antigen concentration was determined in plasmas from normals (n = 40) and from 38 patients with intravascular coagulation as...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Griffin JH,Mosher DF,Zimmerman TS,Kleiss AJ

    更新日期:1982-07-01 00:00:00

  • Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation.

    abstract::Scott syndrome, a bleeding disorder caused by defective phospholipid scrambling, has been associated with mutations in the TMEM16F gene. The role of TMEM16F in apoptosis- or agonist-induced phosphatidylserine (PS) exposure was studied in platelets from a Scott syndrome patient and control subjects. Whereas stimulation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-09-454314

    authors: van Kruchten R,Mattheij NJ,Saunders C,Feijge MA,Swieringa F,Wolfs JL,Collins PW,Heemskerk JW,Bevers EM

    更新日期:2013-03-07 00:00:00

  • Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

    abstract::The clinical and prognostic relevance of many recently identified driver gene mutations in adult acute myeloid leukemia (AML) is poorly defined. We sequenced the coding regions or hotspot areas of 68 recurrently mutated genes in a cohort of 664 patients aged 18 to 86 years treated on 2 phase 3 trials of the German AML...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2016-01-693879

    authors: Metzeler KH,Herold T,Rothenberg-Thurley M,Amler S,Sauerland MC,Görlich D,Schneider S,Konstandin NP,Dufour A,Bräundl K,Ksienzyk B,Zellmeier E,Hartmann L,Greif PA,Fiegl M,Subklewe M,Bohlander SK,Krug U,Faldum A,Berdel

    更新日期:2016-08-04 00:00:00

  • Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.

    abstract::Between 1990 and 1996, we conducted a randomized trial in adults with newly diagnosed acute myeloid leukemia (AML) in order to compare relapse-free interval (RFI) after double induction (arm B), timed-sequential induction (arm C), or control "3 + 7" induction (arm A). Patients achieving complete remission (CR) after i...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood-2003-10-3561

    authors: Castaigne S,Chevret S,Archimbaud E,Fenaux P,Bordessoule D,Tilly H,de Revel T,Simon M,Dupriez B,Renoux M,Janvier M,Micléa JM,Thomas X,Bastard C,Preudhomme C,Bauters F,Degos L,Dombret H

    更新日期:2004-10-15 00:00:00

  • Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy.

    abstract::Dendritic cells (DCs) represent a small and heterogeneous fraction of the hematopoietic system, specialized in antigen capture, processing, and presentation. The different DC subsets act as sentinels throughout the body and perform a key role in the induction of immunogenic as well as tolerogenic immune responses. Bec...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2011-11-370130

    authors: van de Laar L,Coffer PJ,Woltman AM

    更新日期:2012-04-12 00:00:00

  • Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms.

    abstract::The Bcl-2 proto-oncogene was discovered at the t(14;18) breakpoint found in most follicular B-cell lymphomas and some diffuse large-cell lymphomas. Bcl-2 is unique among proto-oncogenes, being localized to mitochondria and extending cell survival by blocking programmed cell death. We examined Bcl-2 protein expression ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zutter M,Hockenbery D,Silverman GA,Korsmeyer SJ

    更新日期:1991-08-15 00:00:00

  • Complete remission in severe aplastic anemia after high-dose cyclophosphamide without bone marrow transplantation.

    abstract::Severe aplastic anemia (SAA) can be successfully treated with allogeneic bone marrow transplantation (BMT) or immunosuppressive therapy. However, the majority of patients with SAA are not eligible for BMT because they lack an HLA-identical sibling. Conventional immunosuppressive therapy also has major limitations; man...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Brodsky RA,Sensenbrenner LL,Jones RJ

    更新日期:1996-01-15 00:00:00